Laura Clague, Chief Financial Officer at Travere Therapeutics, Inc. (TVTX), sold 2,200 shares at $21.51 ($47K) on 2022-05-10, disclosed to the SEC on 2022-05-12.
Scheduled sale ($47k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.51 | 825 | $18K | 37.5% |
| 2 | $21.51 | 1,375 | $30K | 62.5% |
| Total | $21.51 avg | 2,200 | $47K | 100% |
| Filing → |
| TVTX | SELL | 2022-01-26 | $103K | — | Filing → |
| TVTX | SELL | 2022-01-12 | $206K | — | Filing → |
| TVTX | SELL | 2021-08-17 | $24K | — | Filing → |